Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA BLACAT1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 10/March/2019, 1.17 pm
Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA BLACAT1 inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 10/March/2019, 1.17 pm
Spread the love
Spread the love
Let's have a chat!
Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!